Jazz Pharmaceuticals (JAZZ)
Company | Ticker | Sector | Industry | Quality | PAR |
---|---|---|---|---|
Jazz Pharmaceuticals | JAZZ | Healthcare | Biotechnology | 53 | 17.8% |
Current Price ( 4/23 4:00PM EDT) | $109.67 | |||
CAPS Rating (Rate this stock on CAPS) | ||||
Expected Income Statement | ||||
Current Sales | 3,834.2 | |||
Sales Growth Forecast | 6.4% | |||
Net Profit Margin | 28.8% | |||
Projected Shares Outstanding | 60.38 | |||
EPS - Five year Forecast | $24.90 | |||
Average P/E Ratio | 10.0 | |||
Projected Average Price | $249.01 | |||
Price Appreciation (Annualized) | 17.8% | |||
Annual Dividend Yield | 0.0% | |||
Projected Annual Return | 17.8% | |||
Quality | ||||
Financial Strength | 60 | 15.0 | ||
EPS Stability | 57 | 14.4 | ||
Industry Sales Growth Rate | 15.0% | 5.3 | ||
Industry Net Profit Margin | 30.0% | 12.0 | ||
Calculated Quality Rating | 46.7 | |||
Fool CAPS | ||||
Total Players
284
Outperforms
67
Underperforms
All-Stars (61)
40
Outperforms (66%)
21
Underperforms
|
||||
Fundamental Data Updated: 03/01/2024 |